| Ytd | -16.91% | |
| 1y | 36.05% |
| Open | 37.49 | Prev Close | 37.42 | Low | 37.37 | High | 39.40 | Mkt Cap | 4.08B |
| Vol | 1.13M | Avg Vol | 1.21M | EPS | -5.14 | P/E | N/A | Forward P/E | -8.89 |
| Beta | 0.24 | Short Ratio | 13.44 | Inst. Own | 120.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 36.72 | 200-d Avg | 41.80 | 1yr Est | 83.14 |
CRNX News
UBS analyst Ashwani Verma initiates coverage on Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Bu
SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today an
Crinetics Pharmaceuticals maintains a 'Buy' rating due to EU approval and strong initial U.S. uptake
Large-cap pharma is back in the deal market. AbbVie's (NASDAQ: ABBV | ABBV Price Prediction) pending
HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) w
Data from up to two years of treatment in PATHFNDR-1 and PATHFNDR-2 open-label extension studies sho
Data show investigational atumelnant drove sustained androgen reductions while enabling lowering of
Citizens analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Mark
Evercore ISI Group analyst Maneka Mirchandaney maintains Crinetics Pharmaceuticals (NASDAQ:CRNX)
Analysts changed outlook on top names, RBC raised CC price target, DA Davidson lowered MSA target, O
Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outp
Citizens analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Marke
Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(1.23) per share which beat th
Citizens analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Marke
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that the European Commission (EC) has
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced the submission of a Marketing Authoriz
Citizens analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Marke
Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(1.29) per share which beat th
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday'
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company report
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in
On Friday, 469 companies hit new 52-week lows.
On Tuesday, 298 companies achieved new lows for the year.
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 o
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week High Yesterday, August 9th
Stocks Which Set New 52-Week High Yesterday, August 7th
Stocks Which Set New 52-Week Highs Friday, August 3rd